[go: up one dir, main page]

AU2001252513A1 - Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients - Google Patents

Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients

Info

Publication number
AU2001252513A1
AU2001252513A1 AU2001252513A AU5251301A AU2001252513A1 AU 2001252513 A1 AU2001252513 A1 AU 2001252513A1 AU 2001252513 A AU2001252513 A AU 2001252513A AU 5251301 A AU5251301 A AU 5251301A AU 2001252513 A1 AU2001252513 A1 AU 2001252513A1
Authority
AU
Australia
Prior art keywords
tropical
delivery
active ingredients
composition exhibiting
formulation stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252513A
Inventor
David Avnir
Orit Gans
Noa Lapidot
Shlomo Magdassi
Claudio Rottman
Alon Seri-Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sol Gel Technologies Ltd
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of AU2001252513A1 publication Critical patent/AU2001252513A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
AU2001252513A 2000-04-21 2001-04-20 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients Abandoned AU2001252513A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19874900P 2000-04-21 2000-04-21
US60/198,749 2000-04-21
PCT/IL2001/000370 WO2001080823A2 (en) 2000-04-21 2001-04-20 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients

Publications (1)

Publication Number Publication Date
AU2001252513A1 true AU2001252513A1 (en) 2001-11-07

Family

ID=22734655

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252513A Abandoned AU2001252513A1 (en) 2000-04-21 2001-04-20 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients

Country Status (9)

Country Link
EP (2) EP2324812A3 (en)
JP (1) JP4979109B2 (en)
AU (1) AU2001252513A1 (en)
BR (1) BR0110600A (en)
CA (1) CA2406008C (en)
DE (1) DE10182378T1 (en)
ES (1) ES2366886T1 (en)
IL (1) IL152339A0 (en)
WO (1) WO2001080823A2 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20050037087A1 (en) * 2001-11-08 2005-02-17 Noa Lapidot Compositions containing oils having a specific gravity higher than the specific gravity of water
GB0202853D0 (en) * 2002-02-07 2002-03-27 Dow Corning Encapsulation process and encapsulated compositions
GB2385789A (en) * 2002-02-25 2003-09-03 Celessence Internat Ltd Frangible, insect repellent containing microcapsules
EP1358872B1 (en) * 2002-04-30 2008-03-12 Cognis IP Management GmbH Use of mixtures of active compounds comprising azelaic acid and glycyrrhetic acid in the treatment of acne
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
JP4800922B2 (en) * 2003-01-24 2011-10-26 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク Ceramic-based nanoparticles for encapsulating therapeutic agents for photodynamic therapy and methods of use thereof
US8071078B2 (en) 2003-02-26 2011-12-06 Basf Se Encapsulated colorants for natural skin appearance
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
WO2005009604A1 (en) * 2003-07-31 2005-02-03 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
KR20130050395A (en) 2004-03-26 2013-05-15 디에스엠 아이피 어셋츠 비.브이. Composition comprising an hdac inhibitor in combination with a retinoid
GB2416524A (en) * 2004-07-24 2006-02-01 Dow Corning Microcapsules with siloxane walls formed in situ
CN101111225A (en) * 2005-02-03 2008-01-23 金文申有限公司 Drug delivery materials prepared by sol/gel technology
US20080199526A1 (en) * 2005-06-29 2008-08-21 Alexander Poschalko Composition With Tight Capsules Containing a Sunscreen Agent
WO2007012856A1 (en) 2005-07-28 2007-02-01 University Of Hull Uses of sporopollenin
CN101277757B (en) 2005-08-02 2011-11-30 索尔-格尔科技有限公司 Metal oxide coating of water-insoluble components
AU2006296165B2 (en) 2005-09-27 2012-11-08 Sol-Gel Technologies Ltd. Methods for crop protection
US10525433B2 (en) 2006-12-12 2020-01-07 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
EP2120891B9 (en) 2006-12-28 2019-04-24 Dow Silicones Corporation Polynuclear microcapsules
KR101319367B1 (en) 2007-01-03 2013-10-16 주식회사 엘지생활건강 Patch composition for skin-whitening
WO2008093346A2 (en) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
CA2677185C (en) 2007-02-01 2013-12-03 Ofer Toledano Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
US20090047222A1 (en) * 2007-08-15 2009-02-19 Ben Gu Color Stable Peroxide Containing Dentifrice Formulations With Dye Encapsulated Silica Shell Nanoparticles
GB0803538D0 (en) * 2008-02-27 2008-04-02 Dow Corning Deposition of lipophilic active material in surfactant containing compositions
GB0812513D0 (en) 2008-07-09 2008-08-13 Univ Hull Delivery vehicle
KR20110084151A (en) 2008-07-31 2011-07-21 솔-겔 테크놀로지스 리미티드 Microcapsules and metal oxide shells containing the active ingredient, methods for their preparation and uses thereof
EP2373281A2 (en) 2009-01-05 2011-10-12 Sol-Gel Technologies Ltd. Topical compositions containing coated active agents
US8889161B2 (en) 2009-04-27 2014-11-18 Premier Dental Products Company Microencapsulated compositions and methods for tissue mineralization
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
CN102414276B (en) 2009-07-01 2014-06-18 道康宁公司 Microcapsules containing curable siloxanes
US11071878B2 (en) * 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
EP2467132B1 (en) * 2009-12-31 2016-10-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US9993019B2 (en) * 2010-03-26 2018-06-12 Philip Morris Usa Inc. Method for making particle of a hydrophobic additive and a polysaccharide coating and tobacco products containing particle of a hydrophobic additive and a polysaccharide coating
WO2011124706A1 (en) * 2010-04-09 2011-10-13 Basf Se In-situ sol-gel encapsulation of fragrances, perfumes or flavours
WO2011154421A1 (en) * 2010-06-09 2011-12-15 Basf Se Microcapsules containing active substance and having a metal oxide-containing shell
JP6050753B2 (en) 2010-09-30 2016-12-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Method for processing sol-gel capsules
EP2522328A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and ascorbyl-2-glucoside
EP2522335A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and sodium-ascorbyl-phophate
EP2522329A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and arbutin
EP2522332A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and magnesium-ascorbyl-phosphate
EP2522330A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and an edelweiss extract
EP2522331A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
ES2786103T3 (en) 2011-06-29 2020-10-08 Sol Gel Tech Ltd Stabilized topical formulations containing core-shell microcapsules
CN104039301A (en) 2012-01-09 2014-09-10 帝斯曼知识产权资产管理有限公司 Use of danielone and derivatives thereof in skin care
EP2623094A1 (en) 2012-02-02 2013-08-07 DSM IP Assets B.V. Use of an edelweiss extract
CN102580106B (en) * 2012-03-21 2013-07-10 浙江大学 Method for preparing pH-sensitive type polyelectrolyte microcapsule administration carrier
EP2852455B1 (en) 2012-05-22 2019-10-30 DSM IP Assets B.V. Hybrid organic-inorganic nano-particles
EP2689836A1 (en) 2012-07-26 2014-01-29 Basf Se Composition of microcapsules with a silica shell and a method for preparing them
HK1216240A1 (en) 2012-11-14 2016-10-28 W. R. Grace & Co.-Conn. Compostions containing a biologically active material and a non-ordered inorganic oxide
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2014083557A1 (en) * 2012-11-27 2014-06-05 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2014162311A1 (en) 2013-04-01 2014-10-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Adjustable sol-gel-based capsules comprising fragrances and aromas, and uses thereof
EP2986282B1 (en) 2013-04-18 2020-03-25 The Regents of the University of California Nanoscale coatings for encapsulation of biological entities
EP2848286A1 (en) 2013-09-12 2015-03-18 DSM IP Assets B.V. Cosmetic composition comprising chicoric acid
EP2873414A1 (en) 2013-11-19 2015-05-20 DSM IP Assets B.V. Use of an edelweiss extract in hair care for the prevention of hair graying
EP3078415B1 (en) 2013-12-06 2019-11-06 Kao Corporation Method for manufacturing microcapsules
EP3206659B1 (en) 2014-10-17 2019-12-25 DSM IP Assets B.V. Use of a cosmetic composition comprising 10-hydroxystearic acid
WO2016164987A1 (en) 2015-04-17 2016-10-20 The University Of Queensland Composition, particulate materials and methods for making particulate materials.
CN107690331A (en) 2015-06-04 2018-02-13 帝斯曼知识产权资产管理有限公司 Radix Gentianae extract without gentiamarin
CN107809994A (en) 2015-06-30 2018-03-16 宝洁公司 Include the composition of multiple microcapsules colonies
US11085008B2 (en) 2015-06-30 2021-08-10 The Procter & Gamble Company Methods for making compositions containing multiple populations of microcapsules
CN105012173A (en) * 2015-07-09 2015-11-04 常州艾瑞特电子有限公司 Toothpaste for preventing and treating oral ulcer and preparation method thereof
JP6526322B2 (en) 2015-08-20 2019-06-05 ソル − ゲル テクノロジーズ リミテッド Composition for topical administration comprising benzoyl peroxide and adapalene
JP6659019B2 (en) * 2015-12-22 2020-03-04 花王株式会社 Microcapsule and method for producing the same
EP3299083A1 (en) 2016-09-23 2018-03-28 Greenseal Research Ltd Custom-tailored sol-gel derived matrixes for chemical immobilization
US10420743B2 (en) 2017-07-12 2019-09-24 Sol-Gel Technologies Ltd Methods and compositions for the treatment of acne
HRP20251185T1 (en) 2017-07-12 2025-11-21 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
US12478064B2 (en) 2017-11-23 2025-11-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Microcapsules and processes for their preparation
CN113195090B (en) * 2018-10-16 2023-06-20 硅胶实验室制药公司 Adjustable process for the preparation of silica capsules/spheres and its use
CN110192655B (en) * 2019-04-28 2022-02-18 中国科学院上海药物研究所 Microsphere of alpha-tocopherol and preparation method thereof
GB202006988D0 (en) * 2020-05-12 2020-06-24 Cambrian Ventures Ltd Anti-viral preparation and method of manufacturing an antiviral preparation
CN112402271B (en) * 2020-11-28 2022-05-03 科玛化妆品(北京)有限公司 A kind of microcapsule-like precursor and preparation method thereof
JP7707206B2 (en) * 2020-12-28 2025-07-14 花王株式会社 Microcapsules
CN117545547A (en) 2021-06-30 2024-02-09 花王株式会社 Aqueous dispersion of microcapsules

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957971A (en) 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
DE2642032C2 (en) 1976-09-18 1987-04-30 Rupprecht, Herbert, Prof. Dr., 8400 Regensburg Process for incorporating active ingredients into silicon dioxide-containing carrier materials and a silicon dioxide-containing preparation
US4880851A (en) 1987-02-26 1989-11-14 Tohru Yamamoto Aromatic composition and method for the production of the same
ES2042664T3 (en) * 1987-10-01 1993-12-16 American Cyanamid Co PERFECTED METHOD FOR THE PREPARATION OF DIALKYLDICLORSUCCINATES.
IL93134A (en) * 1990-01-23 1997-11-20 Yissum Res Dev Co Doped sol-gel glasses for obtaining chemical interactions
US5520917A (en) * 1992-07-27 1996-05-28 Suzuki Yushi Industries Co., Ltd. Materials in the form of colored spherical fine particles
US5846554A (en) 1993-11-15 1998-12-08 Zeneca Limited Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant
DE4341113B4 (en) 1993-12-02 2006-04-13 IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG Stable multiple X / O / Y emulsion
US5591453A (en) 1994-07-27 1997-01-07 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US5874105A (en) 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
WO1997045367A1 (en) 1996-05-29 1997-12-04 Orion-Yhtymä Oy Dissolvable oxides for biological applications
IL120022A (en) * 1997-01-16 2003-02-12 Yissum Res Dev Co Sunscreens for protection from sun radiation
ES2216360T3 (en) * 1998-02-06 2004-10-16 Seiwa Kasei Co., Ltd. MICROCAPSULA WITH A PARTICULAR WALL AND ITS MANUFACTURING PROCEDURE.
FR2774906B1 (en) * 1998-02-13 2000-05-12 Rhodia Chimie Sa ORGANIC HEART AND MINERAL BARK ENCAPSULATION SYSTEM BASED ON ALUMINUM HYDROXYCARBONATE AND PREPARATION METHOD THEREOF
DE19811900C2 (en) 1998-03-18 2003-12-11 Kallies Feinchemie Ag Biocompatible composite material, process for its production and its use
US6146664A (en) 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6103267A (en) 1998-07-27 2000-08-15 Sunsmart, Inc. Stabilized ascorbic acid, composition, and method of use
JP4920132B2 (en) * 1998-08-13 2012-04-18 ゾル−ゲル テクノロジーズ エルティーディー． Process for the preparation of oxide microcapsules filled with functional molecules and the products obtained thereby
FR2785292B1 (en) * 1998-10-30 2002-06-28 Rhodia Chimie Sa CAPSULES WITH POROUS MINERAL SHELL IN WHICH ARE IMMOBILIZED IN A LIQUID BIOLOGICAL MEDIUM, ONE OR MORE BIOLOGICAL MATERIALS, THEIR PREPARATION PROCESS AND USES
US6238650B1 (en) * 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
AU772153B2 (en) 1999-02-12 2004-04-08 Molecular Insight Pharmaceuticals, Inc. Matrices for drug delivery and methods for making and using the same
EP1181000B1 (en) * 1999-05-25 2007-02-07 Sol-Gel Technologies Ltd. A method for obtaining photostable sunscreen compositions

Also Published As

Publication number Publication date
JP4979109B2 (en) 2012-07-18
EP2324812A3 (en) 2012-09-19
EP1335693A2 (en) 2003-08-20
EP2324812A2 (en) 2011-05-25
CA2406008C (en) 2011-03-15
WO2001080823A2 (en) 2001-11-01
CA2406008A1 (en) 2001-11-01
JP2003534249A (en) 2003-11-18
DE10182378T1 (en) 2012-02-02
BR0110600A (en) 2003-04-15
WO2001080823A3 (en) 2003-05-30
ES2366886T1 (en) 2011-10-26
IL152339A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
AU2001252513A1 (en) Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
AU2002343191A1 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
HUP0400240A3 (en) Combinations of substituted oxazolidinones and other active ingredients and pharmaceutical compositions containing them
HUP0302508A3 (en) Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
HUP0401984A3 (en) Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
AU2001252169A1 (en) Combinations of active ingredients with insecticidal and acaricidal properties
AU1798101A (en) Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
MY129406A (en) Taste masked liquid pharmaceutical compositions
AU2609901A (en) Antimicrobial compositions and methods of use
AU2003256555A1 (en) Controlled delivery of active ingredients and sensory markers
HUP0402497A3 (en) Pharmaceutical compositions containing two activ ingredients and their uses
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
HUP9903216A3 (en) Substituted benzamide and use of them as active ingredient in pharmaceutical compositions
HUP0300653A3 (en) Liquid composition formulations, containing herbicidal active ingredients preparing and use thereof
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AU2002215944A1 (en) Film for active ingredients dermal and transdermal administration
AU2001278516A1 (en) Oral cosmetic composition comprising petroleum jelly enrobing an active agent
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
MY131488A (en) Low dose liquid entecavir formulations and use
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
TWI315308B (en) Compounds with antimicrobial activity and pharmaceutical compositions used as antimicrobial agent
AU2001230543A1 (en) Physiologically active compositions based upon active ingredients of basidiomycotina and araliaceae